Thompson Investment Management Inc. Sells 21,504 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Thompson Investment Management Inc. decreased its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 2.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 726,356 shares of the pharmacy operator’s stock after selling 21,504 shares during the quarter. Thompson Investment Management Inc.’s holdings in Walgreens Boots Alliance were worth $6,777,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Sanctuary Advisors LLC acquired a new position in Walgreens Boots Alliance in the second quarter valued at about $313,000. Czech National Bank lifted its position in shares of Walgreens Boots Alliance by 7.0% during the third quarter. Czech National Bank now owns 145,962 shares of the pharmacy operator’s stock worth $1,308,000 after purchasing an additional 9,512 shares in the last quarter. Brookstone Capital Management lifted its position in shares of Walgreens Boots Alliance by 134.2% during the third quarter. Brookstone Capital Management now owns 37,588 shares of the pharmacy operator’s stock worth $337,000 after purchasing an additional 21,541 shares in the last quarter. CWM LLC lifted its position in shares of Walgreens Boots Alliance by 63.8% during the third quarter. CWM LLC now owns 46,161 shares of the pharmacy operator’s stock worth $414,000 after purchasing an additional 17,980 shares in the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt lifted its position in shares of Walgreens Boots Alliance by 927.1% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 13,516 shares of the pharmacy operator’s stock worth $121,000 after purchasing an additional 12,200 shares in the last quarter. Institutional investors own 58.59% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on WBA shares. Evercore ISI upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research report on Monday, January 13th. Bank of America upped their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. TD Cowen cut their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. Royal Bank of Canada raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Finally, Barclays raised their price objective on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $13.19.

Walgreens Boots Alliance Stock Up 0.7 %

Shares of NASDAQ:WBA opened at $10.12 on Friday. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $22.96. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The company’s fifty day simple moving average is $10.22 and its 200 day simple moving average is $9.82.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The business had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period last year, the business posted $0.66 earnings per share. As a group, equities research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.